BioNexus Gene Lab (BGLC) Capital Expenditures Growth (3y) (2021 - 2026)
BioNexus Gene Lab (BGLC) Capital Expenditures Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 225.67 Bn | 220.77 Bn | 4.43 Bn | 18.74% |
| 2 | Sherwin Williams | 84.74 Bn | 84.44 Bn | 3.34 Bn | -19.28% |
| 3 | Ecolab | 78.90 Bn | 73.77 Bn | 1.95 Bn | - |
| 4 | Air Products & Chemicals | 68.19 Bn | 67.21 Bn | 1.04 Bn | -9.03% |
| 5 | Ppg Industries | 25.36 Bn | 23.77 Bn | 1.81 Bn | -2.52% |
| 6 | Chemical & Mining Co Of Chile | 23.48 Bn | 19.61 Bn | 778.60 Mn | - |
| 7 | LyondellBasell Industries | 21.91 Bn | 19.28 Bn | 2.04 Bn | -3.56% |
| 8 | International Flavors & Fragrances | 21.51 Bn | 20.94 Bn | 853.00 Mn | 5.75% |
| 9 | DuPont de Nemours | 18.83 Bn | 17.09 Bn | 639.00 Mn | -14.83% |
| 10 | BioNexus Gene Lab | 2.28 Mn | -1.25 Mn | 12,982.00 | -79.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -71.23% |
| Dec 31, 2025 | -87.59% |
| Sep 30, 2025 | 29.34% |
| Jun 30, 2025 | 155.08% |
| Mar 31, 2025 | -34.49% |
| Dec 31, 2024 | 46.51% |
| Sep 30, 2024 | 686.13% |
| Jun 30, 2024 | 40.14% |
| Mar 31, 2024 | 200.71% |
| Dec 31, 2023 | -86.95% |
| Jun 30, 2023 | 2,308.56% |
| Mar 31, 2023 | 254.23% |
| Dec 31, 2022 | 315.28% |
| Sep 30, 2022 | -111.64% |
| Jun 30, 2022 | -62.14% |
| Mar 31, 2022 | 61.35% |
| Dec 31, 2021 | 27.53% |
| Mar 31, 2021 | 26.97% |